# Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip

> **NCT04065074** · PHASE2 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 16 (actual)

## Conditions studied

- Osteoarthritis, Hip

## Interventions

- **DRUG:** FX006 32 mg

## Key facts

- **NCT ID:** NCT04065074
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-30
- **Primary completion:** 2019-10-11
- **Final completion:** 2019-12-30
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04065074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04065074, "Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04065074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*